| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $664,153 ) |
| | 2024 | 2024 | MONTANA CANCER CONSORTIUM | 2132 BROADWATER AVE STE A1 | BILLINGS | MT | 59102-4778 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 000 | 11 | NIH | 7/24/2024 | $664,153 |
|
| Issue Date FY: 2023 ( Subtotal = $1,069,045 ) |
| | 2023 | 2023 | MONTANA CANCER CONSORTIUM | 2132 BROADWATER AVE | BILLINGS | MT | 59102-4778 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 000 | 10 | NIH | 8/3/2023 | $1,069,045 |
| | 2023 | 2023 | MONTANA CANCER CONSORTIUM | 2132 BROADWATER AVE | BILLINGS | MT | 59102-4778 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 001 | 10 | NIH | 8/29/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $1,063,933 ) |
| | 2022 | 2022 | MONTANA CANCER CONSORTIUM INC | 2132 BROADWATER AVE STE A1 | BILLINGS | MT | 59102-4778 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 000 | 9 | NIH | 8/1/2022 | $1,063,933 |
|
| Issue Date FY: 2021 ( Subtotal = $972,381 ) |
| | 2021 | 2021 | MONTANA CANCER CONSORTIUM INC | 2132 BROADWATER AVE STE A1 | BILLINGS | MT | 59102-4778 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 000 | 8 | NIH | 8/5/2021 | $972,381 |
|
| Issue Date FY: 2020 ( Subtotal = $881,991 ) |
| | 2020 | 2020 | MONTANA CANCER CONSORTIUM INC | 2132 BROADWATER AVE STE A1 | BILLINGS | MT | 59102-4778 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 002 | 7 | NIH | 8/13/2020 | $881,991 |
| | 2020 | 2019 | MONTANA CANCER CONSORTIUM INC | 2132 BROADWATER AVE STE A1 | BILLINGS | MT | 59102-4778 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 001 | 6 | NIH | 2/10/2020 | $125,723 |
| | 2020 | 2018 | MONTANA CANCER CONSORTIUM INC | 2132 BROADWATER AVE STE A1 | BILLINGS | MT | 59102-4778 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 000 | 5 | NIH | 2/10/2020 | -$125,723 |
|
| Issue Date FY: 2019 ( Subtotal = $872,332 ) |
| | 2019 | 2019 | MONTANA CANCER CONSORTIUM INC | 2132 BROADWATER AVE STE A1 | BILLINGS | MT | 59102-4778 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 001 | 6 | NIH | 8/16/2019 | -$872,332 |
| | 2019 | 2019 | MONTANA CANCER CONSORTIUM INC | 2132 BROADWATER AVE STE A1 | BILLINGS | MT | 59102-4778 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 000 | 6 | NIH | 8/9/2019 | $872,332 |
| | 2019 | 2019 | MONTANA CANCER CONSORTIUM INC | 2132 BROADWATER AVE STE A1 | BILLINGS | MT | 59102-4778 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 001 | 6 | NIH | 8/16/2019 | $872,332 |
|
| Issue Date FY: 2018 ( Subtotal = $943,439 ) |
| | 2018 | 2018 | MONTANA CANCER CONSORTIUM INC | 2132 BROADWATER AVE STE A1 | BILLINGS | MT | 59102-4778 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 001 | 5 | NIH | 9/14/2018 | $194,640 |
| | 2018 | 2018 | MONTANA CANCER CONSORTIUM INC | 2132 BROADWATER AVE STE A1 | BILLINGS | MT | 59102-4778 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 000 | 5 | NIH | 7/30/2018 | $748,799 |
|
| Issue Date FY: 2017 ( Subtotal = $706,794 ) |
| | 2017 | 2017 | MONTANA CANCER CONSORTIUM INC | 2132 BROADWATER AVE STE A1 | BILLINGS | MT | 59102-4778 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 001 | 4 | NIH | 8/14/2017 | $41,000 |
| | 2017 | 2017 | MONTANA CANCER CONSORTIUM INC | 2132 BROADWATER AVE STE A1 | BILLINGS | MT | 59102-4778 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 000 | 4 | NIH | 7/28/2017 | $665,794 |
|
| Issue Date FY: 2016 ( Subtotal = $611,042 ) |
| | 2016 | 2016 | MONTANA CANCER CONSORTIUM | 90 POLY DRIVE SUITE 2 | BILLINGS | MT | 59101-0142 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 000 | 3 | NIH | 8/19/2016 | $611,042 |
|
| Issue Date FY: 2015 ( Subtotal = $692,500 ) |
| | 2015 | 2015 | MONTANA CANCER CONSORTIUM | 90 POLY DRIVE SUITE 2 | BILLINGS | MT | 59101-0142 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 000 | 2 | NIH | 7/31/2015 | $630,000 |
| | 2015 | 2015 | MONTANA CANCER CONSORTIUM | 90 POLY DRIVE SUITE 2 | BILLINGS | MT | 59101-0142 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 001 | 2 | NIH | 9/9/2015 | $62,500 |
|
| Issue Date FY: 2014 ( Subtotal = $730,000 ) |
| | 2014 | 2014 | MONTANA CANCER CONSORTIUM | 90 POLY DRIVE SUITE 2 | BILLINGS | MT | 59101-0142 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 001 | 1 | NIH | 9/19/2014 | $100,000 |
| | 2014 | 2014 | MONTANA CANCER CONSORTIUM | 90 POLY DRIVE SUITE 2 | BILLINGS | MT | 59101 | YELLOWSTONE | USA | U10CA067575 | Montana Cancer Consortium CCOP | 000 | 19 | NIH | 5/28/2014 | $0 |
| | 2014 | 2014 | MONTANA CANCER CONSORTIUM | 90 POLY DRIVE SUITE 2 | BILLINGS | MT | 59101-0142 | YELLOWSTONE | USA | UG1CA189872 | Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | 000 | 1 | NIH | 7/31/2014 | $630,000 |
| | 2014 | 2013 | MONTANA CANCER CONSORTIUM | 90 POLY DRIVE SUITE 2 | BILLINGS | MT | 59101 | YELLOWSTONE | USA | U10CA067575 | Montana Cancer Consortium CCOP | 001 | 19 | NIH | 5/28/2014 | $0 |
|
| Issue Date FY: 2013 ( Subtotal = $447,692 ) |
| | 2013 | 2013 | MONTANA CANCER CONSORTIUM | 90 POLY DRIVE SUITE 2 | BILLINGS | MT | 59101-0142 | YELLOWSTONE | USA | U10CA067575 | Montana Cancer Consortium CCOP | 000 | 19 | NIH | 6/26/2013 | $447,692 |
|
| Issue Date FY: 2012 ( Subtotal = $412,534 ) |
| | 2012 | 2012 | MONTANA CANCER CONSORTIUM | 90 POLY DRIVE SUITE 2 | BILLINGS | MT | 59101-0142 | YELLOWSTONE | USA | U10CA067575 | Montana Cancer Consortium CCOP | 000 | 18 | NIH | 6/1/2012 | $412,534 |
|
| Issue Date FY: 2011 ( Subtotal = $440,926 ) |
| | 2011 | 2011 | MONTANA CANCER CONSORTIUM | 90 POLY DRIVE SUITE 2 | BILLINGS | MT | 59101-0142 | YELLOWSTONE | USA | U10CA067575 | Montana Cancer Consortium CCOP | 000 | 17 | NIH | 7/28/2011 | $440,926 |
|
| Issue Date FY: 2010 ( Subtotal = $574,240 ) |
| | 2010 | 2010 | MONTANA CANCER CONSORTIUM | 90 POLY DRIVE SUITE 2 | BILLINGS | MT | 59101-0142 | YELLOWSTONE | USA | U10CA067575 | Montana Cancer Consortium CCOP | 002 | 16 | NIH | 5/27/2010 | $534,240 |
| | 2010 | 2009 | MONTANA CANCER CONSORTIUM | 90 POLY DRIVE SUITE 2 | BILLINGS | MT | 59101-0142 | YELLOWSTONE | USA | U10CA067575 | Montana Cancer Consortium CCOP | 001 | 15 | NIH | 3/30/2010 | $40,000 |
| | 2010 | 2009 | MONTANA CANCER CONSORTIUM | 90 POLY DRIVE SUITE 2 | BILLINGS | MT | 59101 | YELLOWSTONE | USA | U10CA067575 | Montana Cancer Consortium CCOP | 000 | 15 | NIH | 3/30/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $330,913 ) |
| | 2009 | 2009 | MONTANA CANCER CONSORTIUM | 90 POLY DRIVE SUITE 2 | BILLINGS | MT | 59101-0142 | YELLOWSTONE | USA | U10CA067575 | Montana Cancer Consortium CCOP | 002 | 15 | NIH | 9/8/2009 | $40,000 |
| | 2009 | 2009 | MONTANA CANCER CONSORTIUM | 90 POLY DRIVE SUITE 2 | BILLINGS | MT | 59101-0142 | YELLOWSTONE | USA | U10CA067575 | Montana Cancer Consortium CCOP | 001 | 15 | NIH | 5/26/2009 | $290,913 |
| | 2009 | 2008 | MONTANA CANCER CONSORTIUM | 90 POLY DRIVE SUITE 2 | BILLINGS | MT | 59101 | YELLOWSTONE | USA | U10CA067575 | Montana Cancer Consortium CCOP | 000 | 14 | NIH | 10/24/2008 | $0 |
|
| Issue Date FY: 2008 ( Subtotal = $614,384 ) |
| | 2008 | 2008 | MONTANA CANCER CONSORTIUM | 90 POLY DRIVE SUITE 2 | BILLINGS | MT | 59101 | YELLOWSTONE | USA | U10CA067575 | Montana Cancer Consortium CCOP | 000 | 14 | NIH | 7/29/2008 | $614,384 |
|
| Issue Date FY: 2007 ( Subtotal = $688,000 ) (Continued on the next page) |
|
